Sfoglia per AUTORE
FEA E
Collezione AO Ordine Mauriziano

  

Items : 4

Correction to: A phase II/III randomized clinical trial of CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative chemotherapy versus immediate resection in patIents with resecTable BiliarY tract cancers (BTC) at high risk for recurrence: PURITY study. in BMC cancer / BMC Cancer. 2024 May 6;24(1):563. doi: 10.1186/s12885-024-12328-0.

2024
AO Ordine Mauriziano

Niger M; Nichetti F; Fornaro L; Pircher C; Morano F; Palermo F; Rimassa L; Pressiani T; Berardi R; Gardini AC; Sperti E; Salvatore L; Melisi D; Bergamo F; Siena S; Mosconi S; Longarini R; Arcangeli G; Corallo S; Delliponti L; Tamberi S; Fea E; Brandi G; Rapposelli IG; Salati M; Baili P; Miceli R; Ljevar S; Cavallo I; et alii...

A phase II/III randomized clinical trial of CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative chemotherapy versus immediate resection in patIents with resecTable BiliarY Tract Cancers (BTC) at high risk for recurrence: PURITY study. in BMC cancer / BMC Cancer. 2024 Apr 8;24(1):436. doi: 10.1186/s12885-024-12225-6.

2024
AO Ordine Mauriziano

Niger M; Nichetti F; Fornaro L; Pircher C; Morano F; Palermo F; Rimassa L; Pressiani T; Berardi R; Gardini AC; Sperti E; Salvatore L; Melisi D; Bergamo F; Siena S; Mosconi S; Longarini R; Arcangeli G; Corallo S; Delliponti L; Tamberi S; Fea E; Brandi G; Rapposelli IG; Salati M; Baili P; Miceli R; Ljevar S; Cavallo I; et alii...

TEAM Study: Upfront Docetaxel Treatment in Patients With Metastatic Hormone-Sensitive Prostate Cancer: A Real-World, Multicenter, Retrospective Analysis. in Clinical genitourinary cancer / Clin Genitourin Cancer. 2024 Apr;22(2):56-67.e16. doi: 10.1016/j.clgc.2023.08.006. Epub 2023 Sep 7.

2024
ASL Cuneo 2
ASL Asti
ASL Città di Torino
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AOU Città della Salute di Torino
AOU Novara

Tucci M; Gennari A; Maio MD; Buttigliero C; Ortega C; Rossi M; Vellani G; Airoldi M; Vormola R; Numico G; Depetris I; Comandone A; Buosi R; Stevani I; Guglielmini P; Icardi M; Dionisio R; Cattrini C; Vignani F; Brusa F; Prati V; Ruatta F; Filippi R; Mennitto A; Vana F; Fea E; Vanella P; Pisano C; Turco F; et alii...

Activation of immune responses in patients with relapsed-metastatic head and neck cancer (CONFRONT phase I-II trial): Multimodality immunotherapy with avelumab, short-course radiotherapy, and cyclophosphamide. in Clinical and translational radiation oncology / Clin Transl Radiat Oncol. 2018 Aug 13;12:47-52. doi: 10.1016/j.ctro.2018.08.001. eCollection 2018 Au

2018
AO Ordine Mauriziano

Merlano MC; Merlotti AM; Licitra L; Denaro N; Fea E; Galizia D; Di Maio M; Fruttero C; Curcio P; Vecchio S; Russi EG; Corvò R;